… Core tip: This manuscript reviews the current status of immunosuppressive therapy for
inflammatory bowel disease. It describes the mechanism of action, clinical efficacy and adverse …

… for the treatment of inflammatory bowel disease (IBD). We … immunosuppressive therapy
at inducing remission and preventing relapse in ulcerative colitis (UC) and Crohn's disease …

… Crohn’s disease (CD) and ulcerative colitis (UC) are characterized by continuous or relapsing
intestinal inflammation. Both inflammatory bowel diseases (IBDs) are lifetime diseases. …

… therapies for patients with inflammatory bowel diseases (IBD)… of biologic and
immunosuppressive therapy in IBD, based on … antagonists may be more immunosuppressive than …

… Inflammatory bowel disease [IBD] is characterized by an inadequate inflammatory response
… that leads to bowel damage. Immunosuppression has major beneficial therapeutic effect in …

… Less is known about the impact of immunosuppressive therapies on cancer in IBD patients
who have had a prior (controlled) cancer or have a current (uncontrolled) cancer. The …

… immunosuppressive therapy … immunosuppressive therapy, most consistent disease-related
factors associated with a risk of serious infections in patients with IBD include severe disease …

… In an era of increasing use of immunomodulator therapy and biologics, opportunistic infections
(OI) have emerged as a pivotal safety issue in patients with inflammatory bowel disease (…

… We found that treatment with medications for inflammatory bowel disease including anti-TNF
therapy and immunomodulator therapy significantly improved depressive symptoms and …

… Screening procedures for HBV and HCV infection at diagnosis have been underused in
patients with inflammatory bowel disease. We confirm the role of immunosuppressive therapy in …